US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests
An analysis published in the British Medical Journal suggests that a UK-US trade deal could force the NHS to divert £45 billion from services, potentially leading to 229,000 excess deaths by 2036. The deal was originally intended to help British drug exports avoid US tariffs.
Why it matters
The report highlights the potential long-term public health consequences of international trade agreements on national healthcare systems.
Ministers hailed the deal as a way of avoiding US tariffs. Ministers hailed the deal as a way of avoiding US tariffs. NHS US-UK drug deal could result in 229,000 excess deaths in England, analysis suggests Analysis reveals extent of impact on NHS of placating Donald Trump over price of British medicine exports
The framing focuses heavily on the negative impact of the deal and the criticism of political figures like Donald Trump, reflecting a critical perspective on the trade agreement.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in